List of articles with "Prostate Cancer"

Depend®'s Health Campaign

Depend®'s Health Campaign

United States Chicago Prostate Cancer Depend Ken Griffey
Androgen Receptor Therapies

Androgen Receptor Therapies

USA Las Vegas Prostate Cancer Androgen Receptor AR Therapies
Prostate Cancer Town Hall

Prostate Cancer Town Hall

United States St. Louis Prostate Cancer St. Louis Town Hall PCEC
K36 Therapeutics FDA Approval

K36 Therapeutics FDA Approval

USA Cambridge K36 Therapeutics Prostate Cancer KTX-2001
Efficacy of ATNM-400

Efficacy of ATNM-400

USA San Diego Prostate Cancer Actinium ATNM-400
Co-PSMA Trial Recruitment

Co-PSMA Trial Recruitment

Australia Sydney Prostate Cancer Clarity Pharmaceuticals Co-PSMA Trial
Prostate Cancer Prognosis

Prostate Cancer Prognosis

USA Plymouth Meeting NCCN Prostate Cancer Localized Cancer
Prostate Cancer Prognosis

Prostate Cancer Prognosis

USA Plymouth Meeting Prostate Cancer NCCN Guidelines JNCCN
New Prostate Cancer Trial

New Prostate Cancer Trial

Israel Tel Aviv RedHill Biopharma Opaganib Prostate Cancer
Promising Prostate Cancer Results

Promising Prostate Cancer Results

United Kingdom Oxford Prostate Cancer Blue Earth Lutetium
Urgent Call for Action

Urgent Call for Action

United States Los Angeles Prostate Cancer UCLA IMPACT Program
Prostate Cancer Screening

Prostate Cancer Screening

USA Somerset Prostate Cancer ProCure Proton Therapy PSA Testing
ATNM-400: Prostate Cancer Breakthrough

ATNM-400: Prostate Cancer Breakthrough

United States New Orleans Prostate Cancer Actinium ATNM-400
64Cu-SAR-Bombesin Success

64Cu-SAR-Bombesin Success

Australia Sydney Prostate Cancer Clarity Pharmaceuticals SAR-Bombesin
Hope for Prostate Cancer

Hope for Prostate Cancer

USA Chicago Johnson & Johnson Prostate Cancer AKEEGA
Eubanks Prostate Cancer Awareness

Eubanks Prostate Cancer Awareness

USA Atlanta Prostate Cancer ZERO Prostate Cancer Dwight Eubanks
Promising Cancer Treatment

Promising Cancer Treatment

United States Chicago Johnson & Johnson Prostate Cancer pasritamig
AI Innovations in Cancer Detection

AI Innovations in Cancer Detection

United States Omaha Prostate Cancer ProstatID Bot Image
XTANDI™ Prostate Cancer Study

XTANDI™ Prostate Cancer Study

Japan Tokyo Prostate Cancer XTANDI enzalutamide
Phase III AMPLIFY Trial

Phase III AMPLIFY Trial

Australia Omaha Prostate Cancer Clarity Pharmaceuticals AMPLIFY trial
Promontory Therapeutics Update

Promontory Therapeutics Update

USA New York Prostate Cancer Promontory Therapeutics PT-112
Biden's Cancer Diagnosis

Biden's Cancer Diagnosis

United States Alexandria Prostate Cancer ZERO Cancer Biden Health
ESSA Pharma Q2 Results

ESSA Pharma Q2 Results

USA ESSA Pharma South San Francisco Prostate Cancer NASDAQ EPIX
Accuray's Radiotherapy Breakthrough

Accuray's Radiotherapy Breakthrough

USA Madison Accuray Prostate Cancer CyberKnife System
AI Outperforms MRI

AI Outperforms MRI

United States Culver City Prostate Cancer Avenda Health Unfold AI
Lutetium Therapy for Cancer

Lutetium Therapy for Cancer

United Kingdom Oxford Clinical Trials Prostate Cancer Lutetium Therapy
Men's Health Expo 2025

Men's Health Expo 2025

United States Madison Early Detection Prostate Cancer Men's Health
Prostate Cancer Treatment Insights

Prostate Cancer Treatment Insights

United States Florida Cancer Specialists Fort Myers Prostate Cancer Manish Patel
Nanostics Prostate Study

Nanostics Prostate Study

Canada Calgary Prostate Cancer ClarityDX Prostate Nanostics
Isotroprace UK Launch

Isotroprace UK Launch

London United Kingdom Prostate Cancer Isotopia Isoprotrace
Isoprotrace® Launch

Isoprotrace® Launch

United Kingdom Petah Tikva Prostate Cancer Isotopia Isoprotrace
Isoprotrace® Launch

Isoprotrace® Launch

United Kingdom Petah Tikva Prostate Cancer Isotopia Isoprotrace
MyProstateScore 2.0 Validation

MyProstateScore 2.0 Validation

United States Ann Arbor Prostate Cancer MyProstateScore Lynx Dx
FDA Approval for Pluvicto®

FDA Approval for Pluvicto®

United States Novartis East Hanover Prostate Cancer Pluvicto®
New Prostate Cancer Treatment

New Prostate Cancer Treatment

USA New York Prostate Cancer Actinium ATNM-400
Virginia Offers Free Screenings

Virginia Offers Free Screenings

United States Virginia Prostate Cancer ZERO Prostate Cancer
Human Longevity's Cancer Initiative

Human Longevity's Cancer Initiative

United States South San Francisco Precision Medicine Prostate Cancer Human Longevity
Illuccix® Approved

Illuccix® Approved

Netherlands Utrecht Prostate Cancer Illuccix PSMA-PET
Illuccix® Approvals

Illuccix® Approvals

Brazil Prostate Cancer Telix Pharmaceuticals Illuccix Porto Alegre
ESSA Pharma Meeting

ESSA Pharma Meeting

USA ESSA Pharma South San Francisco Prostate Cancer David Parkinson
Fusion Biopsy Market Growth

Fusion Biopsy Market Growth

None Prostate Cancer Fusion Biopsy Healthcare Market
SECuRE Trial Update

SECuRE Trial Update

Australia Sydney Prostate Cancer Clarity Pharmaceuticals SECuRE Trial
MyProstateScore 2.0 Launch

MyProstateScore 2.0 Launch

USA Ann Arbor Prostate Cancer MyProstateScore Lynx Dx
Clarity's FDA Milestone

Clarity's FDA Milestone

Australia Sydney Prostate Cancer Clarity Pharmaceuticals SAR-bisPSMA
Combatting Cancer Disparities

Combatting Cancer Disparities

United States Washington, D.C. Prostate Cancer ZERO Prostate Mathew Knowles
New Legislation for Cancer Screening

New Legislation for Cancer Screening

United States Washington, D.C. Prostate Cancer Health Advocacy PSA Screening
Levee Medical Funding

Levee Medical Funding

USA Durham, NC Prostate Cancer Levee Medical Voro Scaffold
ESSA Pharma's Q1 Update

ESSA Pharma's Q1 Update

United States ESSA Pharma South San Francisco Prostate Cancer masofaniten
Updates on CONV01-α

Updates on CONV01-α

USA San Francisco Convergent Therapeutics Prostate Cancer CONV01-α
Foresee at ASCO GU 2025

Foresee at ASCO GU 2025

USA San Francisco Foresee Pharmaceuticals Prostate Cancer ASCO GU

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.